secwatch.observer — SEC 8-K summary
======================================

Issuer:     LifeMD, Inc. (LFMD)
CIK:        0000948320
Form:       8-K
Filed at:   2024-05-02T23:59:59+00:00
Accession:  0001493152-24-017571
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

LifeMD appoints Dr. Calum MacRae, Harvard cardiologist, to board
----------------------------------------------------------------

- Dr. MacRae appointed as independent director effective April 26, 2024.
- He is Vice Chair for Scientific Innovation, Brigham and Women's Hospital, and Harvard professor.
- Compensation: 50,000 restricted shares vesting in three annual tranches through 2027.
- MacRae's expertise includes cardiology, virtual care, and chronic disease management.
- Press release issued April 29, 2024; no other material changes reported.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/948320/000149315224017571/0001493152-24-017571-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/948320/000149315224017571/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-017571

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer